Lenalidomide prolongs disease control for multiple myeloma patients after stem ... EurekAlert (press release) Multiple myeloma patients are better equipped to halt progression of this blood cancer if treated with lenalidomide, or Revlimid®, following a stem cell transplant, according to a study co-authored by a physician with the Oregon Health & Science ... |
